Business Context and Reporting Period
Company: Centene Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: November 10, 2025
Event: Regulation FD Disclosure regarding an upcoming presentation at the UBS 2025 Global Healthcare Conference on November 11, 2025.
Key Financial Metrics
This filing does not report historical financial results (revenue, profit, cash flow, or debt) for a specific period. It solely reiterates the Company's previously issued full-year 2025 financial forecasts:
- Full Year 2025 GAAP Diluted Loss per Share: Not to exceed $(12.85).
- Full Year 2025 Adjusted Diluted EPS (Non-GAAP): At least $2.00.
Note: The filing text does not provide clear values for total revenue, operating margins, debt levels, or liquidity positions.
Material Changes
No material changes to financial results or operations are reported in this document. The filing serves to confirm that the financial outlook discussed at the upcoming conference remains consistent with prior guidance.
Guidance, Outlook, and Risks
Management Commentary and Outlook
Management will discuss the Company's financial outlook at the UBS conference, reaffirming the full-year 2025 targets listed above. The Company utilizes Non-GAAP measures (excluding amortization of acquired intangible assets and acquisition/divestiture expenses) to evaluate core business performance.
Risks and Contingencies
The filing includes extensive forward-looking statement disclaimers. Key risks identified include:
- Regulatory changes affecting government-sponsored healthcare programs (Medicaid, Medicare, ACA) and funding levels.
- Fluctuations in medical costs, inflation, and provider behaviors.
- Rate cuts or payment reductions by government payors.
- Challenges in maintaining CMS Star ratings and quality scores.
- Operational risks including cyber-attacks, data security, and third-party vendor compliance.
- Macroeconomic factors such as interest rates, geopolitical events, and potential government shutdowns.
Investor Verification Checklist
- Verify the actual GAAP and Non-GAAP results upon the release of the full-year 2025 earnings report to confirm if the $(12.85) loss and $2.00 adjusted EPS targets were met.
- Review the live webcast or replay of the UBS 2025 Global Healthcare Conference for detailed management commentary on the drivers of the forecast.
- Monitor regulatory updates regarding state and federal healthcare funding and ACA provisions that could impact future profitability.
- Check subsequent filings for any updates to the forward-looking statements, as the Company explicitly states it has no obligation to update them unless required by law.